Common use of Annual Written Progress Report and Commercialization Plan Clause in Contracts

Annual Written Progress Report and Commercialization Plan. Within 45 days following the end of each Contract Year, Licensee will deliver to Licensor a true and accurate written progress report and commercialization plan, certified by an officer of Licensee, that summarizes (i) Licensee’s efforts and accomplishments during the Contract Year to diligently commercialize Licensed Products and Licensed Services, and (ii) Licensee’s development and commercialization plans with respect to Licensed Products and Licensed Services for the next Contract Year. The report shall also cover such activities by Affiliates and Sublicensees. The report shall contain the following information to the extent relevant to the activities under the Agreement: (a) The name of the Licensee, the Patent License Agreement number, the names of any Affiliates and Sublicensees, and the products and services being developed and/or commercialized; (b) The progress toward completing and the plans for completing the applicable milestone events pursuant to Sections 2.4 and 3.1(b); (c) The research and development activities, including status and plans for obtaining any necessary governmental approvals, performed during the past year, and the plans for research and development activities for the next year; and (d) The marketing activities for the past year and planned for the next year, and Licensee’s internal estimate for Sales for the next year.

Annual Written Progress Report and Commercialization Plan. Within 45 days following the end of each Contract Year, Licensee will deliver to Licensor a true and accurate written progress report and commercialization plan, certified by an officer of Licensee, that summarizes (i) Licensee’s efforts and accomplishments during the Contract Year to diligently commercialize Licensed Products and Licensed Services, and (ii) Licensee’s development and commercialization plans with respect to Licensed Products and Licensed Services for the next Contract Year. The report shall also cover such activities by Affiliates and Sublicensees. The report shall contain the following information to the extent relevant to the activities under the Agreement: (a) The name of the Licensee, the Patent License Agreement number, the names of any Affiliates and Sublicensees, and the products and services being developed and/or commercialized; (b) The progress toward completing and the plans for completing the applicable milestone events pursuant to Sections 2.4 Section 2.4, Section 3.1(a) and 3.1(b)Exhibit C; (c) The research and development activities, including status and plans for obtaining any necessary governmental approvals, performed during the past year, and the plans for research and development activities for the next year; and (d) The marketing activities for the past year and planned for the next year, and Licensee’s internal estimate for Sales for the next year.

Annual Written Progress Report and Commercialization Plan. Within 45 days following the end of each Contract Year, Licensee will deliver to Licensor a true and accurate signed written progress report and commercialization plan, certified by an officer of Licenseereport, that summarizes (i) Licensee’s efforts and accomplishments during the Contract Year to diligently commercialize Licensed Products and Licensed Services, and (ii) Licensee’s development and commercialization plans with respect to Licensed Products and Licensed Services for the next Contract Year. The report shall also cover such activities by Affiliates and Sublicensees. The report shall be in the format of Exhibit C and shall contain the following information to the extent relevant to the activities under the Agreement: (a) The name of the Licensee, the Patent & Technology License Agreement number, the names of any Affiliates and Sublicensees, and the products and services being developed and/or commercialized;; and (b) The progress toward completing and the plans for completing the applicable milestone events pursuant to Sections 2.4 and 3.1(b);; and (c) The research and development activities, including status and plans for obtaining any necessary governmental approvalsRegulatory Approvals, performed during the past year, and the plans for research and development activities for the next year; and . Licensee: Blue Water Vaccines, Inc.OTC Exclusive License (dLife Sciences) The marketing activities for the past year and planned for the next year, and Licensee’s internal estimate for Sales for the next year.CONFIDENTIAL